Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1974 Jul;10(1):152–156. doi: 10.1128/iai.10.1.152-156.1974

Slime of Pseudomonas aeruginosa: In Vivo Production

George Dimitracopoulos 1, John W Sensakovic 1, Pasquale F Bartell 1
PMCID: PMC414971  PMID: 4210337

Abstract

Indirect hemagglutination inhibition tests were employed to detect slime in concentrations as low as 1 μg/ml. Increasing concentrations of slime resulted in proportionately greater inhibition of hemagglutination. Peritoneal aspirates and plasma of mice injected with slime were shown to exhibit the inhibitory activity of slime. The rapid dissemination of slime into the peripheral circulation was also indicated by the hemagglutination of mouse erythrocytes by specific anti-slime serum. By similar methods, the inhibitory activity of slime was also detected in peritoneal aspirates and plasma of mice infected with lethal doses of viable Pseudomonas aeruginosa. Furthermore, the inhibitory activity was found to increase with time after viable cell infection, whereas such increases were not detected after the injection of heat-killed organisms. Ferritin-labeled slime antibodies were found to completely surround cells of Pseudomonas aeruginosa obtained from the peritoneal cavity of mice 5 h postinfection.

Full text

PDF

Images in this article

156Image
on p.156

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartell P. F., Orr T. E., Chudio B. Purification and Chemical Composition of the Protective Slime Antigen of Pseudomonas aeruginosa. Infect Immun. 1970 Nov;2(5):543–548. doi: 10.1128/iai.2.5.543-548.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bartell P. F., Orr T. E., Garcia M. The lethal events in experimental Pseudomonas aeruginosa infection of mice. J Infect Dis. 1968 Apr;118(2):165–172. doi: 10.1093/infdis/118.2.165. [DOI] [PubMed] [Google Scholar]
  3. Bartell P. F., Orr T. E., Lam G. K. Polysaccharide depolymerase associated with bacteriophage infection. J Bacteriol. 1966 Jul;92(1):56–62. doi: 10.1128/jb.92.1.56-62.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bass J. A., McCoy J. C. Passive immunization against experimental pseudomonas infection: correlation of protection to verder and evans "o" serotypes. Infect Immun. 1971 Jan;3(1):51–58. doi: 10.1128/iai.3.1.51-58.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brown M. R., Foster J. H., Clamp J. R. Composition of Pseudomonas aeruginosa slime. Biochem J. 1969 May;112(4):521–525. doi: 10.1042/bj1120521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. CALLAHAN W. S., BEYERLEIN B., MULL J. D. TOXICITY OF PSEUDOMONAS AERUGINOSA SLIME. J Bacteriol. 1964 Sep;88:805–806. doi: 10.1128/jb.88.3.805-806.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Foley F. D., Greenawald K. A., Nash G., Pruitt B. A., Jr Pathology of Pseudomonas infection. Tex Med. 1969 Oct;65(10):36–39. [PubMed] [Google Scholar]
  8. Goto S., Enomoto S., Takahashi Y., Motomatsu R. Slime production by Pseudomonas aeruginosa. I. Conditions for slime production by the cellophane plate method. Jpn J Microbiol. 1971 Jul;15(4):317–324. doi: 10.1111/j.1348-0421.1971.tb00587.x. [DOI] [PubMed] [Google Scholar]
  9. HAYNES W. C. Pseudomonas aeruginosa--its characterization and identification. J Gen Microbiol. 1951 Nov;5(5 Suppl):939–950. doi: 10.1099/00221287-5-5-939. [DOI] [PubMed] [Google Scholar]
  10. LIU P. V., ABE Y., BATES J. L. The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. J Infect Dis. 1961 Mar-Apr;108:218–228. doi: 10.1093/infdis/108.2.218. [DOI] [PubMed] [Google Scholar]
  11. SRI RAM J., TAWDE S. S., PIERCE G. B., Jr, MIDGLEY A. R., Jr Preparation of antibody-ferritin conjugates for immunoelectron microscopy. J Cell Biol. 1963 Jun;17:673–675. doi: 10.1083/jcb.17.3.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Schwarzmann S., Boring J. R. Antiphagocytic Effect of Slime from a Mucoid Strain of Pseudomonas aeruginosa. Infect Immun. 1971 Jun;3(6):762–767. doi: 10.1128/iai.3.6.762-767.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Sensakovic J. W., Bartell P. F. The slime of Pseudomonas aeruginosa: biological characterization and possible role in experimental infection. J Infect Dis. 1974 Feb;129(2):101–109. doi: 10.1093/infdis/129.2.101. [DOI] [PubMed] [Google Scholar]
  14. Stone H. H., Given K. S., Martin J. D., Jr Delayed rejection of skin homografts in Pseudomonas sepsis. Surg Gynecol Obstet. 1967 May;124(5):1067–1070. [PubMed] [Google Scholar]
  15. Stone H. H. Review of pseudomonas sepsis in thermal burns: verdoglobin determination and gentamicin therapy. Ann Surg. 1966 Feb;163(2):297–305. doi: 10.1097/00000658-196602000-00023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. TEPLITZ C. PATHOGENESIS OF PSEUDOMONAS VASCULITIS AND SEPTIC LEGIONS. Arch Pathol. 1965 Sep;80:297–307. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES